Prasad Gunasekaran

An American goes to the ER for high blood pressure, stays under 24 hours, no surgery, no CT, no MRI, and gets a $41,000 bill. Lovely. Now here’s the part people miss when this gets discussed economically: that $41,000 fully counts toward U.S. GDP. Not because it’s useful, but because GDP counts priced transactions, not value or outcomes. And it doesn’t stop there. The system creates additional GDP layers around the same visit. Hospital administrative labor, insurance claim processing, billing departments, compliance and coding, insurer overhead and profit, financial services handling payments and debt, interest if the patient can’t pay immediately. So one short ER visit inflates healthcare GDP, inflates services GDP, inflates finance GDP, inflates measured economic activity. Even though nothing extra was medically produced. This is why US GDP looks larger than countries with regulated or single payer healthcare. In Europe, the same visit might cost a few hundred euros, involve minimal billing, and generate far less economic activity on paper. Same patient. Same outcome. Wildly different GDP contribution.